Gene info: ID 5901

Gene: RAN

GENE ID: 5901

Synonyms: ARA24|Gsp1|TC4

Description: RAN, member RAS oncogene family

Gene type: protein-coding

Location: 12q24.33

dbXrefs: Ensembl:ENSG00000132341 MIM:601179 Vega:OTTHUMG00000134328 UniprotKB:P62826

RefSeq: NC_000012.12

Retrived from: PubMed

SNPs: 0 ANCO-SNPs

Phenotype: CD|OD|ND|AD

# Publications: 23

Sherlock p-value : NA (AD) NA (ND) (Frontal_Cortex)

Pascal p-value : 9.453e-1 (AD) 8.880e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
RAB1A	0.976
VDAC2	0.975
PNMA1	0.97
EIF1B	0.968
RAD23B	0.967
CCT7	0.967
CCT2	0.967
MORF4L2	0.966
VDAC1	0.966
AKIRIN2	0.965

Top 10 negatively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
OR4F5	-0.757
OR4F29	-0.716
VNN3	-0.31
P2RY14	-0.293
CXCR2	-0.283
CSAG1	-0.281
MTRNR2L6	-0.278
IL18RAP	-0.276
FZD10	-0.273
MTRNR2L10	-0.271

ID	Drug Name	Drug Type	CAS Num	Status	Role
DB04315	Guanosine-5'-Diphosphate	Small Molecule	146-91-8	Experimental	Target

ID	Drug Name	Action	PubMed
C028474	1,4-bis(2-(3,5-dichloropyridyloxy))benzene	"[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of RAN mRNA"	23626729
C028474	1,4-bis(2-(3,5-dichloropyridyloxy))benzene	"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of RAN mRNA"	23626729
C118559	1-bromopropane	1-bromopropane results in increased expression of RAN protein	27421776
C118559	1-bromopropane	1-bromopropane results in increased expression of RAN protein	21925529
C111118	2',3,3',4',5-pentachloro-4-hydroxybiphenyl	"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of RAN mRNA"	19114083
C016403	2,4-dinitrotoluene	"2,4-dinitrotoluene affects the expression of RAN mRNA"	21346803
C023514	2,6-dinitrotoluene	"2,6-dinitrotoluene affects the expression of RAN mRNA"	21346803
C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of RAN mRNA"	12376462\|1521517
D000082	Acetaminophen	Acetaminophen results in decreased expression of RAN mRNA	22230336
D000517	alpha-Chlorohydrin	alpha-Chlorohydrin analog results in decreased expression of RAN protein	26597043
D000643	Ammonium Chloride	Ammonium Chloride affects the expression of RAN mRNA	16483693
D000643	Ammonium Chloride	Ammonium Chloride results in increased expression of RAN protein	16483693
D000661	Amphetamine	Amphetamine results in increased expression of RAN protein	23459167
D000661	Amphetamine	MDK gene mutant form inhibits the reaction [Amphetamine results in increased expression of RAN protein]	23459167
D017638	Asbestos, Crocidolite	"Asbestos, Crocidolite affects the expression of RAN mRNA"	17331233
D001205	Ascorbic Acid	Ascorbic Acid results in increased expression of RAN mRNA	22139585
D001205	Ascorbic Acid	Ascorbic Acid results in increased expression of RAN protein	22139585
D001280	Atrazine	Atrazine results in decreased expression of RAN mRNA	22378314
C487081	belinostat	belinostat results in decreased expression of RAN mRNA	19606018
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of RAN protein	17292933
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of RAN mRNA	22228805
D004958	Estradiol	Estradiol affects the expression of RAN mRNA	21826169
D004958	Estradiol	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RAN mRNA	20823114
C006780	bisphenol A	bisphenol A affects the expression of RAN mRNA	21826169
C006780	bisphenol A	bisphenol A results in decreased expression of RAN mRNA	29275510
C006780	bisphenol A	bisphenol A results in decreased expression of RAN mRNA	26063408
C006780	bisphenol A	bisphenol A results in increased expression of RAN mRNA	25181051
C006780	bisphenol A	bisphenol A results in increased methylation of RAN gene	28505145
C000611646	bisphenol F	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RAN mRNA	28628672
C013418	bromfenacoum	bromfenacoum results in increased expression of RAN protein	28903499
C032036	bromobenzene	bromobenzene results in increased expression of RAN mRNA	12628495
D015124	8-Bromo Cyclic Adenosine Monophosphate	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RAN mRNA	22079614
D002065	Buspirone	Buspirone results in decreased expression of RAN mRNA	24136188
D002101	Cacodylic Acid	Cacodylic Acid results in increased expression of RAN mRNA	16122865
D002104	Cadmium	Cadmium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RAN protein]	29107029
D002104	Cadmium	Cadmium results in increased expression of RAN mRNA	16624402
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of RAN mRNA	23741332
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of RAN mRNA	16624402
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of RAN protein	21699967
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of RAN mRNA	27339419
D002273	Carcinogens	Carcinogens results in increased expression of RAN mRNA	16316942
D002392	Catechin	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RAN mRNA	24763279
C100187	chloropicrin	chloropicrin results in increased expression of RAN mRNA	26352163
C074702	chromium hexavalent ion	chromium hexavalent ion affects the expression of RAN mRNA	28472532
D002994	Clofibrate	Clofibrate results in increased expression of RAN mRNA	16081524
D002995	Clofibric Acid	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RAN mRNA	17602206
C055162	clopidogrel	clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of RAN mRNA]	19172522
D019327	Copper Sulfate	Copper Sulfate results in decreased expression of RAN mRNA	19549813
C014347	decitabine	decitabine affects the expression of RAN mRNA	17524140
C014347	decitabine	[decitabine co-treated with trichostatin A] results in decreased expression of RAN mRNA	17524140
D003907	Dexamethasone	Dexamethasone results in increased expression of RAN mRNA	21356098
D003907	Dexamethasone	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RAN mRNA	28628672
D003993	Dibutyl Phthalate	Dibutyl Phthalate results in decreased expression of RAN mRNA	21266533
D003994	Bucladesine	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RAN mRNA	20823114
C000944	dicrotophos	dicrotophos results in decreased expression of RAN mRNA	28302478
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RAN mRNA	17602206
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of RAN mRNA	19638242
D015127	9,10-Dimethyl-1,2-benzanthracene	"9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAN mRNA"	12376462
D004298	Dopamine	Dopamine results in increased expression of RAN mRNA	21983523
D004610	Ellagic Acid	Ellagic Acid results in decreased expression of RAN mRNA	12002526
D004785	Environmental Pollutants	Environmental Pollutants results in decreased expression of RAN mRNA	24534155
D004791	Enzyme Inhibitors	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RAN protein	23301498
D000431	Ethanol	Ethanol affects the localization of RAN protein	26185205
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in increased expression of RAN mRNA	16174780\|1940095
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in increased expression of RAN mRNA	16174780\|1710823
D018818	Fenoldopam	Fenoldopam results in increased expression of RAN mRNA	21983523
D018120	Finasteride	Finasteride results in increased expression of RAN mRNA	24136188
D005485	Flutamide	Flutamide results in increased expression of RAN mRNA	24136188
C069837	fullerene C60	fullerene C60 results in decreased expression of RAN mRNA	19167457
C039281	furan	furan results in increased expression of RAN mRNA	22079235\|2619464
D005839	Gentamicins	Gentamicins results in increased expression of RAN mRNA	22061828
D005897	Glafenine	Glafenine results in increased expression of RAN mRNA	24136188
D005947	Glucose	[INS protein co-treated with Glucose] results in decreased expression of RAN mRNA	22634610
C511402	Grape Seed Proanthocyanidins	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RAN mRNA	24763279
D017313	Fenretinide	Fenretinide results in decreased expression of RAN mRNA	28973697
D006820	Hyaluronic Acid	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of RAN protein]	23178681
D006820	Hyaluronic Acid	Hyaluronic Acid analog results in decreased expression of RAN protein	23178681
D006861	Hydrogen Peroxide	Hydrogen Peroxide affects the expression of RAN protein	21179406
D006861	Hydrogen Peroxide	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of RAN protein]	23178681
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in decreased expression of RAN protein	23178681
D006918	Hydroxyurea	Hydroxyurea results in decreased expression of RAN mRNA	12929121
D007052	Ibuprofen	Ibuprofen affects the expression of RAN protein	18351690
C568452	importazole	importazole results in decreased activity of [KPNB1 protein binds to RAN protein]	21469738
D007213	Indomethacin	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RAN mRNA	28628672
D007213	Indomethacin	Indomethacin results in increased expression of RAN mRNA	28201806
D015056	1-Methyl-3-isobutylxanthine	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RAN mRNA	28628672
C561695	(+)-JQ1 compound	(+)-JQ1 compound results in decreased expression of RAN mRNA	20871596
C410337	K 7174	K 7174 results in decreased expression of RAN mRNA	24086573
D048628	Ketolides	Ketolides analog results in decreased expression of RAN mRNA	24967691
D007854	Lead	Lead affects the expression of RAN mRNA	28903495
D007854	Lead	Lead affects the splicing of RAN mRNA	28903495
C002385	linsidomine	linsidomine results in increased oxidation of RAN protein	28086193
D008070	Lipopolysaccharides	clopidogrel inhibits the reaction [Lipopolysaccharides results in increased expression of RAN mRNA]	19172522
D008094	Lithium	Lithium results in increased expression of RAN protein	18296634
D017258	Medroxyprogesterone Acetate	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of RAN mRNA	20823114
D008727	Methotrexate	Methotrexate affects the expression of RAN mRNA	18502557
D008741	Methyl Methanesulfonate	Methyl Methanesulfonate results in decreased expression of RAN mRNA	23649840
D037742	Nanotubes, Carbon	"Nanotubes, Carbon affects the expression of RAN protein"	22001959
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in decreased expression of RAN mRNA"	25620056
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in increased expression of RAN mRNA"	25554681
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in increased expression of RAN mRNA"	25554681
C051752	nefazodone	nefazodone results in increased expression of RAN mRNA	24136188
D009532	Nickel	Nickel results in increased expression of RAN mRNA	25583101
C022838	nickel chloride	nickel chloride affects the expression of RAN mRNA	22546817
C012655	nimesulide	nimesulide results in increased expression of RAN mRNA	24136188
C014707	nitrosobenzylmethylamine	nitrosobenzylmethylamine results in increased expression of RAN mRNA	17616710
C016340	o,p'-DDT	"o,p'-DDT affects the expression of RAN mRNA"	17984292
D010416	Pentachlorophenol	Pentachlorophenol results in increased expression of RAN mRNA	23892564
D010433	Pentylenetetrazole	[Pentylenetetrazole co-treated with Vigabatrin] affects the expression of RAN mRNA	21503142
D010634	Phenobarbital	Phenobarbital affects the expression of RAN mRNA	23091169
D010882	Piperonyl Butoxide	Piperonyl Butoxide results in increased expression of RAN mRNA	22484513
C006253	pirinixic acid	pirinixic acid results in increased expression of RAN mRNA	16221962\|1830175
C006253	pirinixic acid	pirinixic acid results in increased expression of RAN mRNA	22484513
D011285	Pregnenolone Carbonitrile	"[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of RAN mRNA"	23626729
D011374	Progesterone	Progesterone results in decreased expression of RAN mRNA	18037150
D011372	Progestins	Progestins results in increased expression of RAN mRNA	19609016
C045950	propiconazole	propiconazole results in increased expression of RAN mRNA	19363144
D011794	Quercetin	Quercetin results in increased expression of RAN mRNA	21356098
C059514	resveratrol	resveratrol results in decreased expression of RAN mRNA	12002526\|1256957
C089730	rosiglitazone	rosiglitazone results in decreased expression of RAN mRNA	17639046
D012822	Silicon Dioxide	Silicon Dioxide analog affects the secretion of RAN protein	25895662
C009277	sodium arsenate	sodium arsenate results in increased expression of RAN mRNA	16882884
C017947	sodium arsenite	sodium arsenite results in decreased expression of RAN protein	23570992
C017947	sodium arsenite	sodium arsenite results in increased expression of RAN mRNA	24431212
C017947	sodium arsenite	sodium arsenite results in increased expression of RAN mRNA	19822182
C017947	sodium arsenite	sodium arsenite results in decreased expression of RAN protein	19072884
C016104	sodium bichromate	sodium bichromate results in increased expression of RAN mRNA	25993096
D013629	Tamoxifen	Tamoxifen results in increased expression of RAN mRNA	19400957
D013629	Tamoxifen	Tamoxifen results in increased expression of RAN mRNA	19400957
D013749	Tetrachlorodibenzodioxin	Cadmium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RAN protein]	29107029
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of RAN protein	29107029
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of RAN mRNA	21570461
D015647	2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine	"2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased expression of RAN protein"	25852303
D013853	Thioacetamide	Thioacetamide results in increased expression of RAN mRNA	16297948\|2341159
C009495	titanium dioxide	titanium dioxide results in increased expression of RAN mRNA	23557971
C082097	tocotrienol, delta	"tocotrienol, delta results in increased expression of RAN mRNA"	21356098
C066340	tolcapone	tolcapone binds to RAN protein	19783845
C032910	triadimefon	triadimefon results in increased expression of RAN mRNA	19363144
D014241	Trichloroethylene	PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of RAN protein]	15363585
D014241	Trichloroethylene	Trichloroethylene results in increased expression of RAN mRNA	15363585\|1944899
C012589	trichostatin A	trichostatin A results in decreased expression of RAN mRNA	19606018
C012589	trichostatin A	[decitabine co-treated with trichostatin A] results in decreased expression of RAN mRNA	17524140
C015559	trimellitic anhydride	trimellitic anhydride results in increased expression of RAN mRNA	19042947
C057693	troglitazone	troglitazone results in increased expression of RAN mRNA	28973697
C080163	trovafloxacin	trovafloxacin results in decreased expression of RAN mRNA	24136188
D014415	Tunicamycin	Tunicamycin results in decreased expression of RAN mRNA	22378314
D014501	Uranium	Uranium affects the expression of RAN mRNA	15672453
D017974	Uranium Compounds	Uranium Compounds results in decreased expression of RAN mRNA	19654044
C005460	uranyl acetate	uranyl acetate affects the expression of RAN mRNA	15672453
C406224	valdecoxib	valdecoxib results in increased expression of RAN mRNA	24136188
D014635	Valproic Acid	Valproic Acid affects the expression of RAN mRNA	17292431
D014640	Vancomycin	Vancomycin results in decreased expression of RAN mRNA	18930951
D001335	Vehicle Emissions	Vehicle Emissions affects the methylation of RAN gene	25560391
D020888	Vigabatrin	[Pentylenetetrazole co-treated with Vigabatrin] affects the expression of RAN mRNA	21503142
D012256	Riboflavin	Riboflavin results in increased expression of RAN mRNA	21356098

GO/Pathway

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000287	magnesium ion binding	-	IDA	11336674 26272610
GO:0003682	chromatin binding	-	TAS	1961752
GO:0003713	transcription coactivator activity	-	NAS	15572661
GO:0003723	RNA binding	-	HDA	22658674 22681889
GO:0003924	GTPase activity	-	IBA	21873635
GO:0003924	GTPase activity	-	IDA	8636225 26272610
GO:0003924	GTPase activity	-	TAS	10400640
GO:0005049	nuclear export signal receptor activity	contributes_to	IC	14681208
GO:0005515	protein binding	-	IPI	1961752 7603572 9637251 9822603 10557333 10679025 11290418 11336674 11832950 12649209 12724356 14681208 16428860 18266911 18591255 18611384 18617507 19098896 20951941 20972448 21139563 23251006 23435562 23850451 24855949 25416956 26272610 29040603
GO:0005525	GTP binding	-	IDA	1961752 11336674 27541860 29040603
GO:0005525	GTP binding	-	IMP	18938132
GO:0019003	GDP binding	-	IDA	11336674 27541860
GO:0019003	GDP binding	-	IMP	18938132
GO:0045296	cadherin binding	-	HDA	25468996
GO:0046982	protein heterodimerization activity	-	IPI	11336674
GO:0050681	androgen receptor binding	-	NAS	15572661
GO:0070883	pre-miRNA binding	contributes_to	IDA	14681208

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000054	ribosomal subunit export from nucleus	-	IBA	21873635
GO:0000055	ribosomal large subunit export from nucleus	-	IMP	12773398
GO:0000056	ribosomal small subunit export from nucleus	-	IMP	12773398
GO:0000060	protein import into nucleus, translocation	-	IMP	18266911 18691641
GO:0000070	mitotic sister chromatid segregation	-	IMP	29040603
GO:0000278	mitotic cell cycle	-	TAS	8421051
GO:0006259	DNA metabolic process	-	TAS	8421051
GO:0006409	tRNA export from nucleus	-	TAS	-
GO:0006606	protein import into nucleus	-	IBA	21873635
GO:0006606	protein import into nucleus	-	IDA	9822603
GO:0006606	protein import into nucleus	-	IMP	8636225
GO:0006611	protein export from nucleus	-	IDA	16449645
GO:0007052	mitotic spindle organization	-	TAS	10408446
GO:0010586	miRNA metabolic process	-	TAS	-
GO:0016032	viral process	-	TAS	-
GO:0030521	androgen receptor signaling pathway	-	NAS	15572661
GO:0032092	positive regulation of protein binding	-	IDA	16449645
GO:0035281	pre-miRNA export from nucleus	-	IC	14681208
GO:0045540	regulation of cholesterol biosynthetic process	-	TAS	-
GO:0045893	positive regulation of transcription, DNA-templated	-	NAS	15572661
GO:0046039	GTP metabolic process	-	IDA	26272610
GO:0051301	cell division	-	IEA	-
GO:0061015	snRNA import into nucleus	-	IMP	8636225
GO:0075733	intracellular transport of virus	-	TAS	-
GO:1902570	protein localization to nucleolus	-	IMP	18938132

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000785	chromatin	colocalizes_with	IDA	1961752
GO:0005634	nucleus	-	HDA	21630459
GO:0005634	nucleus	-	IBA	21873635
GO:0005634	nucleus	-	IDA	9822603 26308891
GO:0005635	nuclear envelope	-	IDA	27541860
GO:0005643	nuclear pore	-	NAS	8421051
GO:0005654	nucleoplasm	-	IDA	18938132
GO:0005654	nucleoplasm	-	TAS	-
GO:0005730	nucleolus	-	IDA	18938132
GO:0005737	cytoplasm	-	IBA	21873635
GO:0005737	cytoplasm	-	IDA	1961752 26308891
GO:0005814	centriole	-	IDA	19166812
GO:0005829	cytosol	-	TAS	-
GO:0016020	membrane	-	HDA	19946888
GO:0030496	midbody	-	IDA	19166812
GO:0032991	protein-containing complex	-	IDA	11336674
GO:0032991	protein-containing complex	-	IMP	10557333
GO:0042470	melanosome	-	IEA	-
GO:0042565	RNA nuclear export complex	-	IDA	14681208
GO:0043657	host cell	-	IEA	-
GO:0055037	recycling endosome	-	IDA	24561039
GO:0070062	extracellular exosome	-	HDA	19056867 20458337
GO:0090543	Flemming body	NOT	IDA	19166812

KEGG ID	KEGG Term
hsa03008	Ribosome biogenesis in eukaryotes
hsa03013	RNA transport

Reactome ID	Reactome Term	Evidence
R-HSA-1430728	Metabolism	TAS
R-HSA-162587	HIV Life Cycle	TAS
R-HSA-162599	Late Phase of HIV Life Cycle	TAS
R-HSA-162906	HIV Infection	TAS
R-HSA-162909	Host Interactions of HIV factors	TAS
R-HSA-1643685	Disease	TAS
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	TAS
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	TAS
R-HSA-168254	Influenza Infection	TAS
R-HSA-168255	Influenza Life Cycle	TAS
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	TAS
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	TAS
R-HSA-177243	Interactions of Rev with host cellular proteins	TAS
R-HSA-180746	Nuclear import of Rev protein	TAS
R-HSA-203927	MicroRNA (miRNA) biogenesis	TAS
R-HSA-211000	Gene Silencing by RNA	TAS
R-HSA-556833	Metabolism of lipids	TAS
R-HSA-5578749	Transcriptional regulation by small RNAs	TAS
R-HSA-5663205	Infectious disease	TAS
R-HSA-6784531	tRNA processing in the nucleus	TAS
R-HSA-72306	tRNA processing	TAS
R-HSA-74160	Gene expression (Transcription)	TAS
R-HSA-8953854	Metabolism of RNA	TAS
R-HSA-8957322	Metabolism of steroids	TAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID	Title (Year)	Author	Journal
27644166	Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. (2016 Sep 20)	Gotzsche PC	Cochrane Database Syst Rev
10924430	Physical activity and peptic ulcers. Does physical activity reduce the risk of developing peptic ulcers? (2000 Aug)	Cheng Y	West J Med
17399789	Comparative overview of indoor air quality in Antwerp, Belgium. (2007 Aug)	Stranger M	Environ Int
10786867	Does physical activity reduce the risk of developing peptic ulcers? (2000 Apr)	Cheng Y	Br J Sports Med
25228483	Stimulating dialogue: measuring success of the "Smoke Free Horry" campaign. (2013)	Anderson C	Int Q Community Health Educ
25156414	High serum thyrotropin levels are associated with retinal arteriolar narrowing in the general population. (2014 Oct)	Ittermann T	Thyroid
26756459	Intranasal or transdermal nicotine for the treatment of postoperative pain. (2016 Jan 12)	Matthews AM	Cochrane Database Syst Rev
6218813	A study of embolism in mitral valve disease and atrial fibrillation. (1983 Feb)	Dewar HA	Br Heart J
16128225	The relation of the pleural thickening in tuberculosis pleurisy with the activity of adenosine deaminase. (2005 Jun)	Uskul B	Monaldi Arch Chest Dis
12138715	[A correspondence behavioral approach for 6 lifestyle's improvements in a workplace]. (2002 Jun)	Kunitsuka K	Nihon Koshu Eisei Zasshi
17432310	Methadone as an analgesic: a review of the risks and benefits. (2007 Jan-Feb)	Terpening CM	W V Med J
27206466	The association between smoking and psychopathology adjusted for body mass index and gender. (2016 Oct)	Dimitriadis DG	Australas Psychiatry
29510733	Income inequality and cardiovascular disease risk factors in a highly unequal country: a fixed-effects analysis from South Africa. (2018 Mar 6)	Adjaye-Gbewonyo K	Int J Equity Health
9819539	A comparison of maximum oxygen consumption, aerobic performance, and endurance in young and active male smokers and nonsmokers. (1998 Nov)	Song EY	Mil Med
22266156	Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. (2012 Apr)	Nelson RE	Bone
6866196	Gender differences in peak acetaldehyde concentration after an acute dose of ethanol. (1983 Mar-Apr)	Zeiner AR	Neurobehav Toxicol Teratol
16571603	Association of alcohol dehydrogenase genes with alcohol dependence: a comprehensive analysis. (2006 May 1)	Edenberg HJ	Hum Mol Genet
28540162	Effect of brand and advertising medium on demand for e-cigarettes: Evidence from an experimental auction. (2017 Sep)	Rousu MC	Prev Med Rep
17056404	Smoking in eating disorders. (2006 Nov)	Anzengruber D	Eat Behav
18272472	DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. (2008 Mar)	Arizono K	Jpn J Clin Oncol
19744508	Association between physical activity and insulin resistance in Iranian adults: National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). (2009 Nov)	Esteghamati A	Prev Med
24671923	Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. (2014 Mar 26)	Kew KM	Cochrane Database Syst Rev
17686623	Confidence and understanding among general practitioners and practice nurses in the UK about diagnosis and management of COPD. (2007 Nov)	Halpin DM	Respir Med